Interpretation of the relationship between Chinese medicine and traditional Chinese medicine: Will the medicine not be attached?

Release date: 2007-07-26

Interpretation of the relationship between Chinese medicine and traditional Chinese medicine: Will the medicine not be attached?

"Waste medical medicine" is a common problem in the Chinese medicine industry. It still exists in many fields of traditional Chinese medicine, such as the use of proprietary Chinese medicine by clinicians, but not the differentiation of syndromes; the technology of drug research and development in Chinese medicine manufacturers Many people are born in medicinal chemistry or traditional Chinese medicine. Few Chinese medicine professionals participate in research, and there is no one who knows the doctor to carry out after-sales service. The Chinese pharmacists in the hospital only understand medicine, and the medical theory is not solid enough. The consequences of “abolishing medicines” are very serious, and it may eventually lead to a loss of both medicine and medicine. The reporter interviewed relevant experts on this issue.
"Waste medicine deposits" triggered the credibility crisis of traditional Chinese medicine The relationship between Chinese medicine and traditional Chinese medicine is just like the coach of the strategizing and the general who is in charge of the rush. The "detoxification of medicine" is not the traditional Chinese medicine, but the general of Chinese medicine. It can be said that the crisis of Chinese medicine credibility has created an excuse for setting up trade barriers with countries that compete for the herbal market in China.
In the early 1990s, the Chinese medicine pill "Slim Pills" exported from Hong Kong to Western European countries caused serious adverse reactions and became the fuse of the "Aristolochic Acid Incident".
On June 9, 2000, the US Food and Drug Administration (FDA) ordered the cessation of the import, manufacture, and sale of raw materials and finished products known to contain and suspected to contain aristolochic acid. Later, Spain, Austria, Malaysia, the Philippines, Japan and other countries followed suit and announced the ban on the use or removal of the above ingredients, resulting in a worldwide aristolochic acid incident.
At the beginning of 2003, the adverse events of Longdan Xiegan Pill broke out in China, and this incident inevitably triggered the credibility crisis of Chinese medicine. For a time, the concept of less toxic side effects of Chinese medicine was broken, and the safety of taking Chinese medicine was questioned.
The main ingredients of slim pills are amphetamine, bohemian buckthorn, belladonna extract, acetazolamide, anti-self, magnolia, etc. From the perspective of its formula, it does not meet the Chinese medicine, law, prescription and medicine guidance. Principles, and the medications used by the users are generally more than one year, and some are longer than three years. According to the principle of "Chinese medicine is a stop" and "effect must be more square", the patient should not be allowed to take the same drug for a long time. It can be seen that the application of the slime pill is not carried out under the guidance of TCM theory.
"The credibility crisis caused by waste medical drugs first harms the Chinese medicine industry, and the Japanese Xiaochaihu Tang incident is an example," said Lu Guangyu, a senior researcher at the China Academy of Traditional Chinese Medicine. In 1990, the Japanese Ministry of Health and Welfare announced the first use of modern medical and pharmaceutical re-evaluation methods for Xiaochaihu Deco to confirm its safety and effectiveness. After extensive research, the Ministry of Health and Welfare recognized the efficacy of Xiaochaihutang in improving liver dysfunction in patients with liver disease in 1994. Therefore, the party was officially included in the National Pharmacopoeia as a drug for liver disease, and Xiaochaihutang became the drug of choice for the treatment of patients with liver disease. Use throughout the entire course of treatment. In Japan, there have been a million patients with liver disease who are taking Xiaochaihu soup. In March 1996, the media revealed that in the two years since the Ministry of Health and Welfare recognized Xiaochaihu Decoction for the treatment of liver disease, 88 patients with chronic hepatitis have suffered from interstitial pneumonia due to taking Xiaochaihu Decoction, and 10 more have died. The Ministry of Health and Welfare immediately issued an urgent notice to stop Xiaochaihu Tang, and the public responded strongly. In 1995, before the incident, the annual sales of Xiaochaihu Decoction exceeded 25% of the total sales of 147 kinds of Chinese preparations within the scope of Japanese medical insurance. After the Xiaochaihu Tang incident, the production of Japanese Hanfang preparations showed a low tide. And there is a tendency to shrink year by year. Lu Guangtao said: "We should fully understand the dangers of abolishing medicines in order to avoid repeating the mistakes of Japan."
New drug research and development, heavy pharmacology, light solution is not a long-term solution Wang Zhimin, a new drug review expert of the State Food and Drug Administration, said that the approval of new Chinese medicines was originally a pharmacological and partial solution, that is, new drug manufacturers must provide scientific and rigorous pharmacological test results. It is also necessary to provide rational, rational, rational and reasonable solutions for rational, rational, rational, and rational use of contraindications for use in clinical syndrome differentiation. However, due to the large number of Chinese medicine schools in China, the theory of Chinese medicine is sometimes too simple, and there are often different views on the same problem. The drug research and development unit spends a lot of manpower and financial resources to do pharmacological experiments, just because there is controversy in the solution. Obtained. This situation is not conducive to the modernization of Chinese medicine and the Chinese medicine to the world. Therefore, the approval of new Chinese medicines is now more pharmacological and lighter.
Wang Zhimin said that the reason for adopting such an examination and approval method is to realize the rapid development of the Chinese medicine industry and accelerate the modernization of Chinese medicine. The research and development of new medicines is in line with the needs of the development of Chinese medicine at this stage, but in the long run, The modernization of traditional Chinese medicine should also be based on the modernization of medical theory.
In recent years, under the impetus of returning to the trend of returning to the basics, the world's botanical drugs have developed rapidly. The output value of botanical drugs in Europe and the United States has increased at a rate of more than 10% per year. Although China is the birthplace of traditional Chinese medicine, the growth rate is far lower than that. This level. China's Chinese herbal medicines are basically exported only to neighboring countries. In 1995, China's traditional Chinese medicine exports earned 670 million US dollars, reaching the highest level in history, but only accounted for 4.4% of the international market (excluding the mainland China market), which is quite inconsistent with the status of China's traditional Chinese medicine.
Wang Zhimin said: "Compared with foreign pharmaceutical companies, China's pharmaceutical companies have no strong capital, and their technology is not as advanced as others. However, Chinese medicine has an unparalleled advantage. This is because we have Chinese medicine that has condensed the wisdom of the Chinese nation for thousands of years. Theoretical treasures, these theoretical resources are the magic weapon that foreign enterprises can't take away. On the one hand, clinical drugs should be treated according to syndrome differentiation, in order to get the good results of drugs, and on the other hand, because China has a complete set of drug compatibility theory. If you can pay attention to the development of new drugs, you will get twice the result with half the effort. However, if the Chinese medicine production research unit only sees the immediate economic benefits, taking pharmacological research as the most important and ignoring the development of the solution, the result will be counterproductive. The reason why Chinese medicine is different from botanicals It is because Chinese medicine is a whole science. The reason why traditional Chinese medicine is stable and has few toxic side effects is because it has the guidance of traditional Chinese medicine theory. If Chinese medicine development does not pay attention to medical research, it is bound to reduce Chinese medicine to botanical medicine, then there is nothing. Advantages can be said, it is likely to lead to Chinese medicine in the world
Wang Zhimin pointed out that in order to change the current situation of light and heavy pharmacy, Chinese medicine manufacturers and Chinese medicine circles should actively invest in the study of TCM theory to make the theoretical system of TCM more perfect and more rigorous.
Traditional Chinese medicine should complement each other. "Zhou Li": "Physician, the decree of the doctor, the poison to the medical service."
The above sentence makes a concise summary of the relationship between medicines. It means that doctors should be able to use drugs and drugs to achieve medical purposes on the basis of identifying phytotoxicity. It is not difficult to see from this sentence that Chinese medicine is a whole science in which medical science and medicine complement each other. On the one hand, traditional Chinese medicine is part of the overall theory of traditional Chinese medicine; on the other hand, the use of traditional Chinese medicine must be carried out under the guidance of traditional Chinese medicine theory. In "Book of Rites," there is a saying that "the doctor is not the third, and he does not take his medicine." It can be seen that the level of a physician's theory is closely related to the efficacy and side effects of drugs.
Zhang Daning, dean of the Tianjin Institute of Traditional Chinese Medicine, believes that due to the meticulous division of modern science, Chinese medicine and traditional Chinese medicine have become two independent disciplines. The current educational model has separated medicine and medicine, and it is also a phenomenon of the phenomenon of “medical medicine”. the reason. In the past, Chinese medicine practitioners were both familiar with medical science and familiar with traditional Chinese medicine. Physicians and pharmacists were one. Nowadays, clinicians do not recognize medicines and do not know much about medicines; while Chinese pharmacists do not engage in clinical practice, do not understand clinical needs, and know the medical principles are relatively shallow, and it is also the cause of clinical use of traditional Chinese medicines according to the drug specifications without dialectical diagnosis and treatment. one.
Zhang Daning said: "Chinese medicine is a whole science. Traditional Chinese medicine is a part of the whole theory of Chinese medicine. Without the guidance of theory, Chinese medicine will become a passive source of water. It cannot be long-lasting. Medical-based, medicine-based, medical If it does not exist, the medicine will be attached. Therefore, whether the Chinese medicine industry in China can carry out some bold explorations, such as appropriately increasing the number of enrolled students in the continuous reading of the university and the master's degree, the teaching and clinical internship will focus on Chinese medicine. This specialty is carried out. In addition, it can strengthen clinician pharmacology training, pharmacists strengthen medical theory training, etc." (Sohu)

Hollow type Creled 5500M mobile LED Operating Light. The service life of LED shadowless lamp is long (50,000h), far longer than that of traditional tungsten halogen lamp (1,500h), and it is over twenty times of the service life of energy saving lamp. Mobile LED Operating Lamp no welding titanium alloy arm and the streamline-designed lamp cap better meet the design requirements of modern clean laminar flow operation rooms. Its fashionable appearance provides a new attraction for hospital operation rooms.Mobile LED Operating Lamp with real "cold" light source: Using LED as the light source. No worry about the heat of operation area and head.

hollow type operating light

Hollow Mobile OT Lamp

Hollow Mobile OT Lamp,Battery OT LED Light,Dental Operating LED Light,Mobile Surgery Room Light

Shandong Lewin Medical Equipment Co., Ltd. ,